TTrialPathMatch Me to Trials
← Back to trials
RecruitingMyasthenia GravisMGgMG

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Eligible age

18+ yrs

Accepts

All genders

Locations

10 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

ADAPT Forward is a platform study with the aim to look at how safe different drugs are and how well they work for people with myasthenia gravis. The goal is to find the best therapeutic approach to reduce patients' side effects and improve their quality of life.

Sponsor: argenx

You may qualify if…

  • ✓ Is at least 18 years of age and the local legal age of consent for clinical studies
  • ✓ Has been diagnosed with MG with consistent clinical features per the investigator's clinical judgment
  • ✓ If receiving MG therapy, including nonsteroidal immunosuppressive drugs (NSIDs), corticosteroids, or acetylcholinesterase (AChE) inhibitors either in combination or alone, the participant should receive a stable dosage before master protocol screening

You may not qualify if…

  • ✕ Known autoimmune disease or any medical condition other than the indication under study that would interfere with an accurate assessment of clinical symptoms of MG or puts the participant at undue risk
  • ✕ Is MGFA (Myasthenia Gravis Foundation of America) Class V

Where it's recruiting

California

Carlsbad

Florida

Miami · Tampa

Michigan

Detroit

Nevada

Las Vegas

New York

Amherst

North Carolina

Chapel Hill · Durham

Ohio

Cincinnati · Columbus

Tennessee

Chattanooga

Texas

Austin · San Antonio

Source: ClinicalTrials.gov · NCT07294170 · last updated 2026-10-26